Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144


Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge.

Sashihara J, Hoshino Y, Bowman JJ, Krogmann T, Burbelo PD, Coffield VM, Kamrud K, Cohen JI.

PLoS Pathog. 2011 Oct;7(10):e1002308. doi: 10.1371/journal.ppat.1002308. Epub 2011 Oct 20.


Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques.

Leskowitz R, Fogg MH, Zhou XY, Kaur A, Silveira EL, Villinger F, Lieberman PM, Wang F, Ertl HC.

J Virol. 2014 May;88(9):4721-35. doi: 10.1128/JVI.03744-13. Epub 2014 Feb 12.


CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques.

Leskowitz RM, Zhou XY, Villinger F, Fogg MH, Kaur A, Lieberman PM, Wang F, Ertl HC.

J Virol. 2013 Aug;87(15):8351-62. doi: 10.1128/JVI.00852-13. Epub 2013 May 22.


Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host.

Rivailler P, Carville A, Kaur A, Rao P, Quink C, Kutok JL, Westmoreland S, Klumpp S, Simon M, Aster JC, Wang F.

Blood. 2004 Sep 1;104(5):1482-9. Epub 2004 May 18.


An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.

Ohashi M, Fogg MH, Orlova N, Quink C, Wang F.

PLoS Pathog. 2012 Dec;8(12):e1003095. doi: 10.1371/journal.ppat.1003095. Epub 2012 Dec 27.


Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.

Orlova N, Fogg MH, Carville A, Wang F.

Clin Vaccine Immunol. 2011 Sep;18(9):1427-34. doi: 10.1128/CVI.05126-11. Epub 2011 Jul 6.


Therapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques.

Silveira EL, Fogg MH, Leskowitz RM, Ertl HC, Wiseman RW, O'Connor DH, Lieberman P, Wang F, Villinger F.

J Virol. 2013 Dec;87(24):13904-10. doi: 10.1128/JVI.01947-13. Epub 2013 Oct 2.


Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques.

Kutok JL, Klumpp S, Simon M, MacKey JJ, Nguyen V, Middeldorp JM, Aster JC, Wang F.

J Virol. 2004 Apr;78(7):3455-61.


Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus.

Moghaddam A, Koch J, Annis B, Wang F.

J Virol. 1998 Apr;72(4):3205-12.


High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.

Weiss ER, Alter G, Ogembo JG, Henderson JL, Tabak B, Bakiş Y, Somasundaran M, Garber M, Selin L, Luzuriaga K.

J Virol. 2016 Dec 16;91(1). pii: e01562-16. Print 2017 Jan 1.


Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses.

Peng R, Gordadze AV, Fuentes Pananá EM, Wang F, Zong J, Hayward GS, Tan J, Ling PD.

J Virol. 2000 Jan;74(1):379-89.


An animal model for acute and persistent Epstein-Barr virus infection.

Moghaddam A, Rosenzweig M, Lee-Parritz D, Annis B, Johnson RP, Wang F.

Science. 1997 Jun 27;276(5321):2030-3.


A new animal model for Epstein-Barr virus pathogenesis.

Wang F.

Curr Top Microbiol Immunol. 2001;258:201-19. Review. No abstract available.


Supplemental Content

Support Center